Matches in Nanopublications for { ?s ?p "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP929578.RAfzcikAKD3nB-IuAZn-vnwbk1O_XDxySAa7TLr4co_XQ130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929578.RAfzcikAKD3nB-IuAZn-vnwbk1O_XDxySAa7TLr4co_XQ130_provenance.
- NP554477.RA_hZGq-XW0wgA7gYX0_Edv8q4VMueLgY7HY17hUXyWAg130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554477.RA_hZGq-XW0wgA7gYX0_Edv8q4VMueLgY7HY17hUXyWAg130_provenance.
- NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946126.RALIfSVbylnnX1vRXIDDMBl2U66vPf60o_WxLR_n3UNyo130_provenance.
- NP929572.RAIqAW_KK-YoFaS0sgbS2NjqzNnkddQy54SAcn30rDJeo130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929572.RAIqAW_KK-YoFaS0sgbS2NjqzNnkddQy54SAcn30rDJeo130_provenance.
- NP803183.RAzPodrnwfN_EK67TLs857sWW4R0Mpc-_3N3kkdFsq0Ms130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803183.RAzPodrnwfN_EK67TLs857sWW4R0Mpc-_3N3kkdFsq0Ms130_provenance.
- NP929573.RA9YOdoyJOXxD9MLsPQKnMOZ83yl_mTxE0sw4yJkfho4A130_assertion description "[In 4 (31%) of the 13 cases enrolled, intratumoral heterogeneity for MET gain was documented in invasive carcinoma components, wherein all the relatively differentiated carcinoma components showed low-level gain of MET and all the corresponding poorly differentiated carcinomas showed high-level gain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929573.RA9YOdoyJOXxD9MLsPQKnMOZ83yl_mTxE0sw4yJkfho4A130_provenance.